Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal microbiome and Staphylococcus aureus carriage study
NL-OMON48845Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Feb 2019
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of mupirocin and Hexidine in Staphylococcus aureus carriage, sponsored by Erasmus MC. Primary endpoint: Nasal microbiome composition. Started Feb 2019; status: active, not recruiting.
02
Drugs
mupirocinHexidine
03
Conditions
Staphylococcus aureus carriage
Beyond the preview
Go deeper on NL-OMON48845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48845.